Talaporfin sodium
Grundinformationen
- CAS
220201-34-3- Standard-SMILES
C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)[O-])C(=O)[O-])c4nc(cc5[nH]c(cc1[nH]2)c(C)c5CC)C(C)=C4C(=O)[O-])[C@@H](CCC(=O)[O-])[C@@H]3C.[Na+].[Na+].[Na+].[Na+]- InChIKey
JLWROAPZCOJYGT-OBJGRMLXSA-J- Summenformel
- C38H37N5Na4O9
- Durchschnittliche Molmasse
- 799,7 g/mol
- Monoisotopische Masse
- 799,21820488
Überblick
LS11(talaporfin sodium) is an agent consisting of chlorin e6, derived from chlorophyll, and L-aspartic acid with photosensitizing activity. After intratumoral activation by light emitting diodes, taporfin sodium forms an extended high energy conformational state that generates singlet oxygen, resulting in free radical-mediated cell death. It is used to treat many kinds of cancers.
Namen und Bezeichner
- Bevorzugter Name
- Talaporfin sodium
- IUPAC
- tetrasodium;(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate
- Englischer Name
- Talaporfin sodium
- Summenformel
- C38H42N5NaO9
- Molmasse
- 735.77
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
220201-34-3、220680-62-6- PubChem CID
- 5488036
- DTXSID
DTXSID70420519- UNII
- L63605PZ70
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 247 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 11
- Frei drehbare Bindungen
- 8
- Schwere Atome
- 56
- Formalladung
- 0
- Komplexität
- 1.340
Physikochemische Eigenschaften
- storage temp.
- 2 · under inert gas (nitrogen or Argon) at 2-8°C
- Löslichkeit
- 2 · DMSO:2.0(Max Conc. mg/mL);2.5(Max Conc. mM)Water:50.0(Max Conc. mg/mL);62.52(Max Conc. mM)
- Aggregatzustand
- A solid
- Farbe
- Purple to black
- SMILES
- O=C(C[C@H](NC(C/C1=C2[C@@H](CCC(O[Na])=O)[C@H](C)C(/C=C3N/C(C(C=C)=C\3C)=C\C4=N/C(C(CC)=C4C)=C\C5=C(C(C(O[Na])=O)=C1N5)C)=N\2)=O)C(O[Na])=O)O[Na]
Sicherheit und Regulatorisches
Sicherheitsdaten
- wgk
- WGK 3
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Pharmakologische Informationen
Mechanism of Action
Light Sciences Oncology (LSO) aims to en-light-en cancer patients. Light Sciences has developed Light Infusion Therapy (Litx) which is a novel treatment for solid tumors. The therapy involves inserting a flexible light-emitting diode (LED) into a tumor, followed by an injection of LS11 (talaporfin sodium), a light-activated drug. Once the LED activates LS11, molecular oxygen is converted into singlet oxygen, killing tissue within the LED's scope and shutting down the blood supply to the area. The treatment is designed for use on three types of cancers: hepatoma (liver cancer), metastatic colorectal cancer, and Gioma (brain tumor).
Anwendungen
VerwendenTalaporfin sodium is photosensitizer for use in photodynamic therapy to destroy tumor tissue.
Anbieter24 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…